Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials. (February 2019)

Record Type:: Journal Article
Title:: Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials. (February 2019)
Main Title:: Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials
Authors:: Sayar, Hamid
Cripe, Larry D.
Saliba, Antoine N.
Abu Zaid, Mohammad
Konig, Heiko
Boswell, H. Scott
Abstract:
Is Part Of:: Leukemia research. Volume 77(2019)
Journal:: Leukemia research
Issue:: Volume 77(2019)
Issue Display:: Volume 77, Issue 2019 (2019)
Year:: 2019
Volume:: 77
Issue:: 2019
Issue Sort Value:: 2019-0077-2019-0000
Page Start:: 30
Page End:: 33
Publication Date:: 2019-02
Subjects:: Acute myeloid leukemia -- AML -- Sorafenib -- Vorinostat -- Bortezomib
Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:: http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.leukres.2018.12.011 ↗
Languages:: English
ISSNs:: 0145-2126
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 9423.xml